Alliance Pharma Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Nick Sedgwick
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 7.3yrs |
| Board average tenure | 1.2yrs |
Recent management updates
Recent updates
Investors Aren't Entirely Convinced By Alliance Pharma plc's (LON:APH) Revenues
Sep 10
Is Alliance Pharma (LON:APH) A Risky Investment?
Jun 21Not Many Are Piling Into Alliance Pharma plc (LON:APH) Just Yet
Feb 23Estimating The Intrinsic Value Of Alliance Pharma plc (LON:APH)
Nov 21We Think Alliance Pharma (LON:APH) Is Taking Some Risk With Its Debt
May 26Alliance Pharma plc Just Missed Earnings - But Analysts Have Updated Their Models
Mar 24We Think Alliance Pharma (LON:APH) Can Stay On Top Of Its Debt
Sep 30An Intrinsic Calculation For Alliance Pharma plc (LON:APH) Suggests It's 41% Undervalued
May 28Alliance Pharma (LON:APH) Has A Pretty Healthy Balance Sheet
Mar 30Did Alliance Pharma's (LON:APH) Share Price Deserve to Gain 81%?
Dec 24Do Fundamentals Have Any Role To Play In Driving Alliance Pharma plc's (LON:APH) Stock Up Recently?
Nov 19
CEO
Nick Sedgwick (52 yo)
less than a year
Tenure
Mr. Nicholas John Sedgwick, also known as Nick, is Chief Executive Officer and Director of Alliance Pharma plc from May 13, 2024. Sedgwick brings thirty years of consumer health experience across European,...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CFO & Executive Director | 9.3yrs | UK£310.18k | 0.036% £ 84.9k | |
| CEO & Director | less than a year | no data | no data | |
| Chief Scientific Affairs Officer | no data | no data | no data | |
| Head of Investor Relations & Corporate Communications | no data | no data | no data | |
| Group General Counsel & Company Secretary | 7.3yrs | no data | no data | |
| Chief Commercial & Corporate Development Officer | no data | no data | no data | |
| Chief People Officer | 2yrs | no data | no data | |
| Global Marketing Head of Kelo-Cote | 8yrs | no data | no data | |
| Head of Sourcing | no data | no data | no data |
7.3yrs
Average Tenure
Experienced Management: APH's management team is seasoned and experienced (7.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CFO & Executive Director | 9.3yrs | UK£310.18k | 0.036% £ 84.9k | |
| CEO & Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 1.9yrs | UK£48.22k | no data | |
| Senior Independent Non-Executive Director | 6yrs | UK£58.84k | 0.013% £ 29.9k | |
| Independent Non Executive Chair | less than a year | no data | no data | |
| Independent Non-Executive Director | 3.1yrs | UK£52.80k | no data | |
| Independent Non-Executive Director | 1.2yrs | UK£7.27k | no data | |
| Independent Non-Executive Director | 1.2yrs | UK£7.27k | no data | |
| Member of Supervisory Board | less than a year | no data | no data |
1.2yrs
Average Tenure
55yo
Average Age
Experienced Board: APH's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/08 07:54 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Alliance Pharma plc is covered by 16 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Samuel England | Berenberg |
| Julie Simmonds | Canaccord Genuity |
| Mark Brewer | Cavendish |